BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-7 out of 7 found
  Current Search:  ranexa: 7     

HTML
100%
Gilead Fourth Quarter Profit Rises 43% on Atripla Sales
FOSTER CITY, Calif.

(AP) ' Gilead Sciences Inc.

said Tuesday its profit climbed 43 percent in the fourth quarter due to rising sales of its three-in-one HIV drug Atripla.

The company said sales of Atripla, which was approved in the U.S.

in July 2006,...

PharmaceuticalProcessing:  Jan 29 2010 2:44AM
Matching: ranexa
Find similar documents
HTML
100%
Gilead 4Q Profit Rises 43 Percent on Atripla Sales
FOSTER CITY, Calif.--Gilead Sciences Inc.

said Tuesday its profit climbed 43 percent in the fourth quarter due to rising sales of its three-in-one HIV drug Atripla.

The company said sales of Atripla, which was approved in the U.S.

in July 2006, jumped 50...

Pharma Live:  Jan 27 2010 12:46PM
Matching: ranexa
Find similar documents
HTML
100%
Gilead Sciences' 3-in-1 HIV treatment became its top drug in 4Q as Atripla sales rose 50 pct
FOSTER CITY, CALIF.

Gilead Sciences Inc.

said Tuesday its profit climbed 43 percent in the fourth quarter due to rising sales of its three-in-one HIV drug Atripla.

The company said sales of Atripla, which was approved in the U.S.

in July 2006, jumped 50...

DCExaminer.com:  Jan 26 2010 11:11PM
Matching: ranexa
Find similar documents
HTML
100%
Gilead 4Q profit rises 43 percent on Atripla sales
FOSTER CITY, Calif.

-- Gilead Sciences Inc.

said Tuesday its profit climbed 43 percent in the fourth quarter due to rising sales of its three-in-one HIV drug Atripla.

The company said sales of Atripla, which was approved in the U.S.

in July 2006, jumped...

Forbes.com:  Jan 26 2010 10:58PM
Matching: ranexa
Find similar documents
HTML
100%
Gilead 4Q profit rises 43 percent on Atripla sales
FOSTER CITY, Calif.

(AP) -- Gilead Sciences Inc.

said Tuesday its profit climbed 43 percent in the fourth quarter due to rising sales of its three-in-one HIV drug Atripla.The company said sales of Atripla, which was approved in the U.S.

in July 2006,...

Yahoo! Canada:  Jan 26 2010 10:48PM
Matching: ranexa
Find similar documents
HTML
100%
Ranexa (ranolazine extended-release tablets)
_ Ranexa (ranolazine extended-release tablets).
Medscape:  Jan 26 2010 6:14AM
Matching: ranexa
Find similar documents
HTML
100%
TargetCast tcm Acquires Triumph360
Subscribe to Pharmaceutical News on Ulitzer: Email Alerts Weekly Newsletters Get Pharmaceutical News on Ulitzer: Homepage Mobile RSS Facebook Twitter LinkedIn Pharmaceuticals Authors: Don Nelson Related Topics: CEOs in Technology, CIO/CTO Update, SEO Journal,...
Ulitzer:  Jan 13 2010 1:29AM
Matching: ranexa
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.